Legal status · Canada
Is Beinaglutide legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Beinaglutide is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
Beinaglutide in Canada at a glance
| Classification | Not approved |
|---|---|
| Note | No Health Canada submission located. |
| Health Canada approval status | Not approved by Health Canada |
| Human studies cited | 3 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Beinaglutide profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
No product containing Beinaglutide is approved by Health Canada for any use in Canada, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Canada. This page is general information, not legal advice.
What Beinaglutide is
The only marketed GLP-1 drug that is the unmodified human hormone, which is why it has to be injected three times a day. Approved in China, and in a 427 person phase 3 it produced 6.0 percent weight loss against 2.4 percent on placebo over 16 weeks.
Every other drug in this class is the human hormone rebuilt to survive in the bloodstream: an amino acid swapped to resist the enzyme that degrades it, a fatty acid chain added to bind albumin, a protein domain fused on to slow clearance. Beinaglutide is none of that.
Mechanism: Recombinant human glucagon-like peptide-1 (7-36) amide, produced in a recombinant system and identical in sequence to the endogenous hormone. It activates the GLP-1 receptor exactly as the native hormone does: glucose-dependent insulin secretion from pancreatic beta cells, glucagon suppression, delayed gastric emptying and reduced food intake through vagal and central pathways.
Regulatory history: Not approved in the United States. Marketed in China for type 2 diabetes, and approved by China's National Medical Products Administration in July 2023 for weight management.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Beinaglutide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Beinaglutide in other countries
Frequently asked questions
Is Beinaglutide legal in Canada?
No. Beinaglutide is not an approved medicine in Canada; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile. Note: No Health Canada submission located.
Can I buy Beinaglutide in Canada?
No approved product exists to buy. In Canada Beinaglutide is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No Health Canada submission located.
Is Beinaglutide Health Canada approved?
No. In Canada Beinaglutide is classified as "Not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved in the United States. Marketed in China for type 2 diabetes, and approved by China's National Medical Products Administration in July 2023 for weight management.. On the evidence, 3 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Beinaglutide live on its compound profile.
Beinaglutide profileThis page is general information about the regulatory status of Beinaglutide in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.